Growth hormone receptor (GHR) expression is elevated in one third of patients with gliomas, and GHR signaling affects the expression of proteins involved in cell motility, enhancing cell migration, invasion, and proliferation in vitro and carcinogenesis, tumor growth, and tumor invasion in vivo [133,134]. The gene discussed is GHR; the disease is neoplasm.